Variant Creutzfeldt-Jakob disease: Risk of transmission by blood and blood products

Haemophilia, Supplement

Volumn 10, Issue 4, 2004, Pages 64-69

  Ironside, James W ^a   Head, M W ^a  

^a National Creutzfeldt Jakob Disease Surveillance Unit   (United Kingdom)

Author keywords

Blood; BSE; Infectivity; Prions; Variant CJD

Indexed keywords

PRION PROTEIN;

ARTICLE; BLOOD; BLOOD DONOR; BLOOD TRANSFUSION; BOVINE SPONGIFORM ENCEPHALOPATHY; CAUSE OF DEATH; CREUTZFELDT JAKOB DISEASE; DISEASE ASSOCIATION; ERYTHROCYTE CONCENTRATE; EXPOSURE; FRACTIONATION; HUMAN; IATROGENIC DISEASE; LYMPHOCYTE; LYMPHOID TISSUE; NONHUMAN; PATHOGENESIS; PRION DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; RISK REDUCTION; SCREENING TEST; SHEEP; UNITED KINGDOM; VIRUS INFECTIVITY; VIRUS PARTICLE; VIRUS TRANSMISSION;

EID: 11044228082     PISSN: 13550691     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2004.00982.x     Document Type: Article

References (30)

1. Ironside JW. Creutzfeldt-Jakob disease. Brain Pathol 1996; 6: 379-88.
2. Prusiner SB. Prions. Proc Nat Acad Sci USA 1998; 95 13363-83.
3. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216: 136-44.
4. Goldfarb LG, Brown P, Cervenakova L, Gajdusek DC. Molecular genetic studies of Creutzfeldt-Jakob disease. Mol Neurobiol 1994; 8: 89-97.
5. Ironside JW, Head MW, Bell JE, McCardle L, Will RG. Laboratory diagnosis of variant Creutzfeldt-Jakob disease. Histopathology 2000; 37: 1-9.
6. Ward HJ, Everington D, Croes EA et al. Sporadic Creutzfeldt-Jakob disease and surgery: a case-control study using community controls. Neurology 2002; 59: 543-8.
7. Alperovitch A, Zerr I, Pocchiari M et al. Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease. Lancet 1999; 353: 1673-4.
8. Glatzel M, Abela E, Maissen M, Aguzzi A. Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N Engl J Med 2003; 349: 1812-20.
9. Esmonde TFG, Will RG, Slattery JM et al. Creutzfeldt-Jakob disease and blood transfusion. Lancet 1993; 341: 205-7.
10. Brown P. Can Creutzfeldt-Jakob disease be transmitted by transfusion? Curr Opin Haematol 1995; 2: 472-7.
11. Brown P, Preece M, Brandel J-P et al. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 2000; 55 1075-81.
12. Evatt B, Austin H, Barnhart E et al. Surveillance for Creutzfeldt-Jakob disease in patients with haemophilia. Transfusion 1998; 38: 817-20.
13. Lee CA, Ironside JW, Bell JE et al. Retrospective neuropathological review of prion disease in UK haemophiliac patients. Thromb Haemost 1998; 80: 909-11.
14. Will RG, Ironside JW, Zeidler M et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996; 347: 921-5.
15. Ironside JW, McCardle L, Horsburgh A, Lim Z, Head MW. Pathological diagnosis of variant Creutzfeldt-Jakob disease. APMIS 2002; 110: 79-87.
16. Collinge J, Sidle KC, Meads J, Ironside J, Hill AF. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 1996; 383: 685-90.
17. Hill AF, Butterworth RJ, Joiner S et al. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 1999; 353: 183-9.
18. Head MW, Ritchie D, Smith N et al. Peripheral tissue involvement in sporadic, iatrogenic and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative and biochemical study. Am J Pathol 2004; 164: 143-53.
19. Hilton DA, Fathers E, Edwards P, Ironside JW, Zajicek J. Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet 1998; 352: 703-4.
20. Bruce ME, McConnell I, Will RG, Ironside JW. Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues. Lancet 2001; 358: 208-9.
21. Aguzzi A. Prion diseases, blood and the immune system. concerns and reality. Haematologica 2000; 85: 3-10.
22. Bruce ME, Will RG, Ironside JW et al. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 1997; 389: 498-501.
23. Scott MR, Will R, Ironside J et al. Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc Natl Acad Sci USA 1999; 96 15137-42.
24. Brown P, Rohwer RG, Dunstan BC, MacAuley C, Gajdusek DC, Drohan WN. The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy. Transfusion 1998; 38: 810-6.
25. Cervenakova L, Yakovleva O, McKenzie C et al. Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS strains of transmissible spongiform encephalopathy. Transfusion 2003; 43: 1687-94.
26. Stenland CJ, Lee DC, Brown P, Petteway SR Jr, Rubenstein R. Partitioning of human and sheep forms of the pathogenic prion protein during the purification of therapeutic proteins from human plasma. Transfusion 2002; 42: 1497-500.
27. Gregori L, Maring JA, MacAuley C et al. Partitioning of TSE infectivity during ethanol fractionation of human plasma. Biologicals 2004; 32: 1-10.
28. Hunter N, Foster J, Chong A et al. Transmission of prion diseases by blood transfusion. J Gen Virol 2002; 83: 2897-905.
29. Llewelyn CA, Hewitt PE, Knight RS et al. Possible transfusion of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004; 363: 417-21.
30. Turner ML. Variant Creutzfeldt-Jakob disease and blood transfusion. Curr Opin Hematol 2001; 8: 372-9.